Royal Bank Of Canada Issues Positive Forecast for Healthpeak Properties (NYSE:DOC) Stock Price

Key Points

• Royal Bank of Canada raised Healthpeak Properties’ price target from $21 to $24 and maintained an “outperform” rating, implying 14.14% upside from the prior close.
• Despite RBC’s bullish view, the broader analyst consensus remains “Hold,” with four Buy ratings, 15 Holds, and an average price target of $21.15.
• Healthpeak reported quarterly EPS of $0.08, beating estimates by $0.05, while revenue rose 11.1% year over year to $771.58 million; shares recently traded down 1.8% at $21.03.

Healthpeak Properties (NYSE:DOC - Get Free Report) had its price target lifted by research analysts at Royal Bank Of Canada from $21.00 to $24.00 in a research note issued to investors on Monday,Benzinga reports. The brokerage currently has an "outperform" rating on the real estate investment trust's stock. Royal Bank Of Canada's target price indicates a potential upside of 14.14% from the stock's previous close.

A number of other research firms have also recently commented on DOC. Wells Fargo & Company upped their price target on shares of Healthpeak Properties from $20.00 to $22.00 and gave the stock an "equal weight" rating in a report on Wednesday, July 15th. Barclays began coverage on shares of Healthpeak Properties in a report on Tuesday, July 7th. They set an "equal weight" rating and a $23.00 price objective for the company. UBS Group boosted their price objective on shares of Healthpeak Properties from $19.00 to $21.50 and gave the company a "neutral" rating in a research report on Wednesday, July 8th. Citigroup upped their target price on shares of Healthpeak Properties from $17.50 to $20.00 and gave the stock a "neutral" rating in a research note on Tuesday, May 12th. Finally, JPMorgan Chase & Co. lifted their price target on shares of Healthpeak Properties from $18.00 to $21.00 and gave the company a "neutral" rating in a research note on Wednesday, June 24th. Four research analysts have rated the stock with a Buy rating and fifteen have assigned a Hold rating to the company. Based on data from MarketBeat, the stock presently has an average rating of "Hold" and an average price target of $21.15.

Healthpeak Properties Trading Down 1.8%

Shares of DOC stock traded down $0.38 on Monday, reaching $21.03. 1,169,914 shares of the company's stock were exchanged, compared to its average volume of 8,571,724. Healthpeak Properties has a 52 week low of $15.70 and a 52 week high of $22.95. The company has a current ratio of 3.02, a quick ratio of 3.02 and a debt-to-equity ratio of 1.06. The stock has a market capitalization of $14.50 billion, a PE ratio of 60.07, a P/E/G ratio of 3.31 and a beta of 1.01. The company's fifty day simple moving average is $21.20 and its 200 day simple moving average is $18.81.

Healthpeak Properties (NYSE:DOC - Get Free Report) last announced its quarterly earnings data on Tuesday, August 4th. The real estate investment trust reported $0.08 EPS for the quarter, beating the consensus estimate of $0.03 by $0.05. Healthpeak Properties had a return on equity of 2.79% and a net margin of 8.24%.The company had revenue of $771.58 million for the quarter, compared to the consensus estimate of $725.64 million. During the same quarter in the prior year, the company posted $0.46 EPS. Healthpeak Properties's quarterly revenue was up 11.1% on a year-over-year basis. Healthpeak Properties has set its FY 2026 guidance at 1.730-1.770 EPS. As a group, analysts forecast that Healthpeak Properties will post 1.76 EPS for the current year.

Insider Transactions at Healthpeak Properties

In other Healthpeak Properties news, insider Scott R. Bohn sold 10,989 shares of the stock in a transaction dated Tuesday, May 12th. The shares were sold at an average price of $19.45, for a total transaction of $213,736.05. Following the transaction, the insider directly owned 7,636 shares in the company, valued at $148,520.20. This represents a 59.00% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. 0.23% of the stock is currently owned by insiders.

Institutional Investors Weigh In On Healthpeak Properties

Hedge funds have recently modified their holdings of the business. Norges Bank purchased a new stake in shares of Healthpeak Properties during the 4th quarter valued at $153,550,000. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC grew its stake in Healthpeak Properties by 694.6% during the 3rd quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 8,016,692 shares of the real estate investment trust's stock worth $153,520,000 after buying an additional 7,007,777 shares during the last quarter. Bank of New York Mellon Corp grew its stake in Healthpeak Properties by 60.3% during the 1st quarter. Bank of New York Mellon Corp now owns 15,456,420 shares of the real estate investment trust's stock worth $253,949,000 after buying an additional 5,815,189 shares during the last quarter. Fuller & Thaler Asset Management Inc. increased its position in Healthpeak Properties by 19.2% during the 4th quarter. Fuller & Thaler Asset Management Inc. now owns 29,648,260 shares of the real estate investment trust's stock valued at $476,744,000 after buying an additional 4,776,056 shares in the last quarter. Finally, Massachusetts Financial Services Co. MA increased its position in Healthpeak Properties by 214.0% during the 2nd quarter. Massachusetts Financial Services Co. MA now owns 4,230,551 shares of the real estate investment trust's stock valued at $98,050,000 after buying an additional 2,883,382 shares in the last quarter. Hedge funds and other institutional investors own 93.57% of the company's stock.

About Healthpeak Properties

Healthpeak Properties, Inc is a real estate investment trust (REIT) specializing in healthcare-related real estate. Headquartered in Irvine, California, the company owns, develops and acquires a diversified portfolio of properties that cater to the evolving needs of the healthcare industry. Its investments span life science research facilities, medical office buildings and senior housing communities, positioning Healthpeak as a key provider of specialized real estate assets.

Within its life science segment, Healthpeak develops and leases laboratory and research space to biotechnology, pharmaceutical and other life science companies.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source